These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8498383)

  • 1. Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction.
    Baskin JM; Wilkins ML; Ohman EM; Clemmensen P; Grande P; Christenson RH; Sevilla DC; Wagner NB; Wagner GS
    Am J Cardiol; 1993 Jun; 71(15):1362-5. PubMed ID: 8498383
    [No Abstract]   [Full Text] [Related]  

  • 2. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used.
    Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J
    Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction.
    Lavin F; Kane M; Forde A; Gannon F; Daly K
    Br Heart J; 1995 May; 73(5):422-7. PubMed ID: 7786656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction.
    Vuotikka P; Uusimaa P; Niemelä M; Väänänen K; Vuori J; Peuhkurinen K
    Int J Cardiol; 2003 Oct; 91(2-3):137-44. PubMed ID: 14559123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinase.
    Derad I; Stierle U; Giannitsis E; Potratz J; Born J; Djonlagic H; Fehm HL
    Jpn Heart J; 1996 Jan; 37(1):33-41. PubMed ID: 8632624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency QRS electrocardiography in the detection of reperfusion following thrombolytic therapy.
    Aversano T; Rudikoff B; Washington A; Traill S; Coombs V; Raqueno J
    Clin Cardiol; 1994 Apr; 17(4):175-82. PubMed ID: 8187367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolytic therapy of acute myocardial infarction].
    Chen JL
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):69-70. PubMed ID: 15808085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic therapy of acute myocardial infarction].
    Chen HZ
    Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):5-6. PubMed ID: 8404321
    [No Abstract]   [Full Text] [Related]  

  • 10. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD
    Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of acute myocardial infarction in the 1990s.
    Flores ED; Lange RA; Cigarroa RG; Hillis LD
    Am J Med Sci; 1990 Jun; 299(6):415-24. PubMed ID: 2113353
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum myoglobin and creatine kinase enzymes in acute myocardial infarction treated with Anistreplase.
    McCullough DA; Harrison PG; Forshall JM; Irving JB; Hillman RJ
    J Clin Pathol; 1992 May; 45(5):405-7. PubMed ID: 1597518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.
    White HD; Cross DB; Williams BF; Norris RM
    Br Heart J; 1990 Sep; 64(3):177-81. PubMed ID: 2119665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations].
    Roguin A; Manaster J; Roguin N
    Harefuah; 1993 Jun; 124(12):770-5. PubMed ID: 8375772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombolytic therapy in acute myocardial infarction].
    Mazza F; Ciappa G; Contiello V; Morra G; Adinolfi L
    Recenti Prog Med; 1987; 78(7-8):377-80. PubMed ID: 3122287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic thrombolytic treatment in myocardial infarct].
    Davi R; Copello F; Pareti G; Freggiaro V; Morelloni S; Corazza M; Fasciolo L; Allegri M
    Clin Ter; 1990 Aug 15-31; 134(3-4):223-35. PubMed ID: 2147625
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolysis in acute myocardial infarction.
    Holmberg SR
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy: an overview.
    Quaal SJ
    J Cardiovasc Nurs; 1986 Nov; 1(1):45-56. PubMed ID: 3639919
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood viscosity and platelet function in thrombolytic therapy of acute myocardial infarction.
    Hoffmann JJ
    Eur Heart J; 1990 Aug; 11 Suppl F():29-35. PubMed ID: 2121489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which thrombolytic agent should one choose?
    Topol EJ
    Prog Cardiovasc Dis; 1991; 34(3):165-78. PubMed ID: 1947122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.